Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No.
作者信息
Mitin Timur
机构信息
Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon.
出版信息
Int Braz J Urol. 2017 Mar-Apr;43(2):188-191. doi: 10.1590/S1677-5538.IBJU.2017.02.04.
Abstract
摘要
相似文献
1
Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No.根治性膀胱切除术是大多数肌层浸润性膀胱癌患者的最佳选择吗？| 观点：不是。
Int Braz J Urol. 2017 Mar-Apr;43(2):188-191. doi: 10.1590/S1677-5538.IBJU.2017.02.04.
2
Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.根治性膀胱切除术是大多数肌层浸润性膀胱癌患者的最佳选择？| 观点：是。
Int Braz J Urol. 2017 Mar-Apr;43(2):184-187. doi: 10.1590/S1677-5538.IBJU.2017.02.03.
3
[Alternatives to cystectomy].[膀胱切除术的替代方案]
Urologe A. 2015 Apr;54(4):504-9. doi: 10.1007/s00120-015-3775-6.
4
Non-muscle-invasive bladder cancer: the role of radical cystectomy.非肌层浸润性膀胱癌：根治性膀胱切除术的作用
Urology. 2005 Nov;66(5):917-22. doi: 10.1016/j.urology.2005.05.003.
5
Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer.重新审视根治性膀胱切除术作为大多数肌层浸润性膀胱癌患者的最佳选择。
JAMA Oncol. 2016 Jul 1;2(7):856-8. doi: 10.1001/jamaoncol.2016.0152.
6
Invasive T1 bladder cancer: indications and rationale for radical cystectomy.浸润性T1期膀胱癌：根治性膀胱切除术的适应症及理论依据
BJU Int. 2008 Aug;102(3):270-5. doi: 10.1111/j.1464-410X.2008.07743.x. Epub 2008 May 20.
7
The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.机器人辅助根治性膀胱切除术的学习曲线：来自国际机器人膀胱切除术协会的结果。
Eur Urol. 2010 Aug;58(2):197-202. doi: 10.1016/j.eururo.2010.04.024. Epub 2010 Apr 23.
8
Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.低剂量放化疗后行部分或根治性膀胱切除术治疗肌层浸润性膀胱癌：意向性生存分析
Urology. 2008 Aug;72(2):384-8. doi: 10.1016/j.urology.2008.03.017. Epub 2008 May 2.
9
Muscle Invasive Bladder Cancer (MIBC) - The Gold Standard Radical Cystectomy or Bladder Preserving Approach, YES or NO?肌肉浸润性膀胱癌（MIBC）——金标准根治性膀胱切除术还是膀胱保留方法，是或否？
J Pak Med Assoc. 2018 Oct;68(10):1425-1426.
10
Alternatives to cystectomy in muscle-invasive bladder cancer.肌层浸润性膀胱癌膀胱切除术的替代方案。
J Clin Oncol. 2003 Aug 1;21(15):3003; author reply 3003-4. doi: 10.1200/JCO.2003.99.015.
引用本文的文献
1
Survey results of US radiation oncology providers' contextual engagement of watch-and-wait beliefs after a complete clinical response to chemoradiation in patients with local rectal cancer.美国放射肿瘤学提供者对局部直肠癌患者放化疗后完全临床缓解时观察等待理念的情境参与度调查结果
J Gastrointest Oncol. 2018 Dec;9(6):1127-1132. doi: 10.21037/jgo.2018.08.02.
2
Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.肌层浸润性膀胱癌保器官治疗的系统评价和荟萃分析。
World J Urol. 2018 Dec;36(12):1997-2008. doi: 10.1007/s00345-018-2384-6. Epub 2018 Jun 25.
本文引用的文献
1
Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.肌层浸润性膀胱癌长期生存者的生活质量。
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1028-1036. doi: 10.1016/j.ijrobp.2016.08.023. Epub 2016 Aug 24.
2
Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer.重新审视根治性膀胱切除术作为大多数肌层浸润性膀胱癌患者的最佳选择。
JAMA Oncol. 2016 Jul 1;2(7):856-8. doi: 10.1001/jamaoncol.2016.0152.
3
Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer.根治性膀胱切除术与肌层浸润性膀胱癌的多学科管理
JAMA Oncol. 2016 Jul 1;2(7):855-6. doi: 10.1001/jamaoncol.2016.0149.
4
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.细胞色素P450 24A1（CYP24A1）基因变异会改变雌激素加孕激素疗法的使用与结直肠癌风险之间的关联。
Br J Cancer. 2016 Jan 19;114(2):221-9. doi: 10.1038/bjc.2015.443. Epub 2016 Jan 14.
5
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.根治性膀胱切除术与肌肉浸润性膀胱癌的保留器官三联疗法：一项临床试验的系统评价
Crit Rev Oncol Hematol. 2015 Sep;95(3):387-96. doi: 10.1016/j.critrevonc.2015.04.006. Epub 2015 Apr 17.
6
Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.三联疗法在浸润性膀胱癌保膀胱治疗中的应用。
Curr Urol Rep. 2013 Apr;14(2):109-15. doi: 10.1007/s11934-012-0301-x.
7
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.多学科治疗和积极监测低危前列腺癌。
J Clin Oncol. 2012 Sep 1;30(25):3071-6. doi: 10.1200/JCO.2012.42.8466. Epub 2012 Jul 30.
8
Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer.挽救性膀胱切除术治疗肌层浸润性膀胱癌保膀胱治疗失败后的并发症和长期结果。
J Urol. 2012 Feb;187(2):463-8. doi: 10.1016/j.juro.2011.09.159. Epub 2011 Dec 15.
9
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.浸润性膀胱癌患者膀胱保留治疗后的晚期盆腔毒性：放射治疗肿瘤学组89-03、95-06、97-06、99-06研究
J Clin Oncol. 2009 Sep 1;27(25):4055-61. doi: 10.1200/JCO.2008.19.5776. Epub 2009 Jul 27.
10
A population based assessment of perioperative mortality after cystectomy for bladder cancer.基于人群的膀胱癌膀胱切除术后围手术期死亡率评估。
J Urol. 2009 Jul;182(1):70-7. doi: 10.1016/j.juro.2009.02.120. Epub 2009 May 17.
Zotero 插件